Medigene

Medigene EBITDA per Employee

Delisted·Jul 2, 2026

The EBITDA per Employee of Medigene (MDG1.DE) as of Oct 23, 2026 is -107,632.35 EUR. In the previous year, EBITDA per Employee was 95,080.88 EUR — a change of -213.20% (lower).

EBITDA per Employee

-107,632.35EUR

YoY

-213.20%

Last updated:

EBITDA per Employee of Medigene is 2023 -107,632.35 EUR. EBITDA per Employee of Medigene was 2022 95,080.88 EUR. It decreases by -213.20% lower compared to the previous year.

The Medigene EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2016
-60,720.59 EUR
Jan 1, 2017
-89,632.35 EUR
Jan 1, 2018
-119,801.47 EUR
Jan 1, 2019
-133,426.47 EUR
Jan 1, 2020
-140,742.65 EUR
Jan 1, 2021
-49,183.82 EUR
Jan 1, 2022
95,080.88 EUR
Jan 1, 2023
-107,632.35 EUR
The Medigene EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-107,632.35EUR-213.20%
95,080.88EUR-293.32%
-49,183.82EUR-65.05%
-140,742.65EUR+5.48%
-133,426.47EUR+11.37%
-119,801.47EUR+33.66%
-89,632.35EUR+47.61%
-60,720.59EUR-13.05%
-69,830.88EUR+358.57%
-15,227.94EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medigene Stock analysis

What does Medigene do? Medigene AG, based in Planegg, Germany, is a biotechnology company specializing in developing innovative cancer treatment platforms. The company focuses on personalized T cell-based immunotherapies, including TCR-modified T cells for adoptive therapy, dendritic cell vaccines for low tumor burdens, and T-cell-specific monoclonal antibodies. It operates offices in Martinsried, Germany, and in Washington DC and San Diego, USA, with 136 employees. Medigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigene stock

EBITDA per Employee of Medigene is -107,632.35 EUR in 2023.

EBITDA per Employee of Medigene changed from 95,080.88 EUR to -107,632.35 EUR, representing a -213.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Medigene since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Medigene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Medigene

All Key Metrics — Medigene